---
title: "prifemilast — Stuff That Spins"
description: "Narrative intelligence for prifemilast: 1 tracked articles, claims, and spin patterns across AI and technology coverage."
	canonical: "https://stuffthatspins.com/entities/prifemilast"
html: "https://stuffthatspins.com/entities/prifemilast"
json: "https://stuffthatspins.com/entities/prifemilast.json"
markdown: "https://stuffthatspins.com/entities/prifemilast.md"
keywords: ["prifemilast", "product", "AI", "technology", "spin analysis"]
json_ld: |
  {"@context":"https://schema.org","@graph":[{"@type":"Product","@id":"https://stuffthatspins.com/entities/prifemilast","name":"prifemilast","description":"Narrative intelligence for prifemilast across AI and technology coverage.","url":"https://stuffthatspins.com/entities/prifemilast","identifier":"prifemilast"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"prifemilast","item":"https://stuffthatspins.com/entities/prifemilast"}]},{"@type":"ItemList","name":"Articles about prifemilast","itemListElement":[{"@type":"ListItem","position":1,"url":"https://stuffthatspins.com/spin/campfield-strengthens-leadership-team-with-key-executive-appointments-including-graham-heap-md-phd-as-president-rd-to-ad","name":"cAMPfield Strengthens Leadership Team with Key Executive Appointments, Including Graham Heap, MD, PhD as President, R&D, to Advance Prifemilast into Global Phase 2 Development for Inflammatory Bowel Disease"}]},{"@type":"ItemList","name":"Claims involving prifemilast","itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"Claim","text":"cAMPfield is advancing prifemilast into global Phase 2 development for inflammatory bowel disease."}}]}]}
---

# prifemilast

**Type:** product  
## Related Articles

- [cAMPfield Strengthens Leadership Team with Key Executive Appointments, Including Graham Heap, MD, PhD as President, R&D, to Advance Prifemilast into Global Phase 2 Development for Inflammatory Bowel Disease](https://stuffthatspins.com/spin/campfield-strengthens-leadership-team-with-key-executive-appointments-including-graham-heap-md-phd-as-president-rd-to-ad) — August 3, 2026

## Related Claims

- cAMPfield is advancing prifemilast into global Phase 2 development for inflammatory bowel disease.

---
*HTML version: https://stuffthatspins.com/entities/prifemilast*